Board approved CARE Ratings' Q4 FY26 monitoring report on preferential issue fund utilization.
ESOP 2024 allotment deferred for consideration in an upcoming board meeting.
Regulatory filing submitted to BSE and NSE under SEBI Listing Regulations.